Amgen
Company ● Covered in 1 story + Follow ✴ AI Graph Claim this company
Amgen is tracked in TLDRocket’s company dataset. Explore the recorded developments, relationships and supporting evidence below. Coverage reflects our monitored sources and may be incomplete.
Signals
—
Media momentum
As of 1 Nov 2026 · Visible stories in the last 30 days, compared with the 30 days before.
1 source
Source diversity
As of 1 Nov 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 1 Nov 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 1 Nov 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Aug 2025
Coverage span
As of 1 Nov 2026 · First to most recent month of TLDRocket coverage of this entity.
Management records
updated 6 Aug 2026Observed in public listings; this is not a verified current management roster.
- Robert A. Bradway Chairman & CEO
- Howard Chang SVP, Global Research & Chief Scientific Officer
- Esteban Santos Executive Vice President, Operations
- Derek Miller SVP, HR
- Paul Burton SVP & Chief Medical Officer
- Murdo Gordon EVP, Global Commercial Operations
- Scott Skellenger Senior Vice President And Chief Information Officer
- Naveen Gullapalli Managing Director
- David M. Reese Executive Vice President
- Jonathan Graham EVP, General Counsel & Secretary
- Jackie Elbonne SVP, Quality & Chief Quality Officer
- David Piccin Executive Director, Operating Rhythm, And Chief Of Staff To The Chairman And CEO
+ 28 more tracked
Latest developments
Q3 2025
Other: Amgen & GPT-5 Other
Relationships
Products & technology
- Deploys GPT-5 · 1 source